Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis and asthma. Recently, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback